content: <?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
    <headerData>
      <submissionType>144</submissionType>
      <filerInfo>
        <filer>
          <filerCredentials>
            <!-- Field: Pseudo-Tag; ID: Name; Data: ORBIMED ADVISORS LLC -->
            <cik>0001055951</cik>
            <ccc>XXXXXXXX</ccc>
          </filerCredentials>
        </filer>
        <liveTestFlag>LIVE</liveTestFlag>
  
  
  
      </filerInfo>
    </headerData>
    <formData>
      <issuerInfo>
        <issuerCik>0001528287</issuerCik>
        <issuerName>NeuroPace Inc.</issuerName>
        <secFileNumber>001-40337</secFileNumber>
        <issuerAddress>
          <com:street1>455 N. Bernardo Avenue</com:street1>
          <com:city>Mountain View</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>94043</com:zipCode>
        </issuerAddress>
        <issuerContactPhone>650-237-2700</issuerContactPhone>
        <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>OrbiMed Private Investments VI, LP</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
        <relationshipsToIssuer>
          <relationshipToIssuer>Shareholder</relationshipToIssuer>
        </relationshipsToIssuer>
      </issuerInfo>
      <securitiesInformation>
        <securitiesClassTitle>Common Stock</securitiesClassTitle>
        <brokerOrMarketmakerDetails>
          <name>JP Morgan Chase &amp; Co.</name>
          <address>
            <com:street1>270 Park Ave.</com:street1>
            <com:city>New York</com:city>
            <com:stateOrCountry>NY</com:stateOrCountry>
            <com:zipCode>10017</com:zipCode>
          </address>
        </brokerOrMarketmakerDetails>
        <noOfUnitsSold>288100</noOfUnitsSold>
        <aggregateMarketValue>2558328.00</aggregateMarketValue>
        <noOfUnitsOutstanding>25859643</noOfUnitsOutstanding>
        <approxSaleDate>10/02/2023</approxSaleDate>
        <securitiesExchangeName>Nasdaq Stock Market</securitiesExchangeName>
      </securitiesInformation>
      <securitiesToBeSold>
        <securitiesClassTitle>Common Stock</securitiesClassTitle>
        <acquiredDate>04/26/2021</acquiredDate>
        <natureOfAcquisitionTransaction>IPO</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>288100</amountOfSecuritiesAcquired>
        <paymentDate>04/26/2021</paymentDate>
        <natureOfPayment>Cash</natureOfPayment>
      </securitiesToBeSold>
      <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
      <remarks>OrbiMed Capital GP VI LLC is the general partner of OrbiMed Private Investments VI, LP. OrbiMed Advisors LLC is the managing member of OrbiMed Capital GP VI LLC.</remarks>
      <noticeSignature>
        <noticeDate>10/02/2023</noticeDate>
        <signature>/s/ Douglas Coon, Chief Compliance Officer, OrbiMed Advisors LLC, managing member of the general partner of OrbiMed Private Investments VI, LP</signature>
      </noticeSignature>
    </formData>
  </edgarSubmission>
metadata_documents: [{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 3121}]
text: 144
  0001055951
  XXXXXXXX
  LIVE
  0001528287
  NeuroPace Inc.
  001-40337
  455 N. Bernardo Avenue
  Mountain View
  CA
  94043
  650-237-2700
  OrbiMed Private Investments VI, LP
  Shareholder
  Common Stock
  JP Morgan Chase & Co.
  270 Park Ave.
  New York
  NY
  10017
  288100
  2558328.00
  25859643
  10/02/2023
  Nasdaq Stock Market
  Common Stock
  04/26/2021
  IPO
  Issuer
  N
  288100
  04/26/2021
  Cash
  Y
  OrbiMed Capital GP VI LLC is the general partner of OrbiMed Private Investments VI, LP. OrbiMed Advisors LLC is the managing member of OrbiMed Capital GP VI LLC.
  10/02/2023
  /s/ Douglas Coon, Chief Compliance Officer, OrbiMed Advisors LLC, managing member of the general partner of OrbiMed Private Investments VI, LP